MegaPro Biomedical Co., Ltd.TPEX: 6827

MegaPro Submits Application To FDA To Conduct Phase III Trial On MPB-1523

· Issued by MegaPro Biomedical Co., Ltd.

On 6ix: 6ix.com/news/megapro-submits-application-to-fda-to-conduct-phase-iii-trial-on-mpb-1523

MegaPro Biomedical Co Ltd TPEX:6827:

  • SAYS CO SUBMITS APPLICATION TO U.S. FDA TO CONDUCT PHASE III CLINICAL TRIAL ON NEW DRUG MPB-1523

MegaPro Biomedical Co., Ltd. on 6ix